Sign in
4

Changes in Ownership

Denali Therapeutics Inc. Filed Acc 0001714899-22-000008

President and CEO sold 5,007 shares at $44.78 ($224,213)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I In the form
Watts Ryan J. President and CEO 2022-01-05 Sale −5,007 $44.78 $224,213 2,113,361 I
Open-market sales · 5,007 sh · avg $44.78 · $224,213
Loading xslF345X03/wf-form4_164159676820157.xml…